HROW

Harrow Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth 8/10
  • Value 2/10
Harrow sales and earnings growth
HROW Growth
Good
  • Revenue Y/Y 20.88%
  • EPS Y/Y 36.07%
  • FCF Y/Y 3295.01%
Harrow gross and profit margin trends
HROW Profitability
Neutral
  • Gross margin 74.10%
  • EPS margin -5.60%
  • ROIC 5Y 1.80%
Harrow net debt vs free cash flow
HROW Risk
Poor
  • Debt / Equity 10.6
  • Debt / FCF 14.4
  • Interest coverage 0.5

Harrow stock volatility is in-line with the overall market. We give it a Poor risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks